【7446】東北化学薬品
化学工業薬品、臨床検査試薬。
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025.09 | 2024/11/14 | 当初予 | 33,700 | - | - | - | 420 | - | - | - | 490 | - | - | - | 310 | - | - | - |
2024.09 | 2024/11/14 | 実 | 32,155 | ↓ | -0.4% | -0.4% | 353 | ↓ | -19.8% | -19.8% | 407 | ↓ | -16.9% | -16.9% | 237 | ↓ | -25.9% | -25.9% |
2024.09 | 2024/08/01 | Q3予 | 32,300 | → | 0.0% | 0.0% | 440 | → | 0.0% | 0.0% | 490 | → | 0.0% | 0.0% | 320 | → | 0.0% | 0.0% |
2024.09 | 2024/05/01 | Q2予 | 32,300 | → | 0.0% | 0.0% | 440 | → | 0.0% | 0.0% | 490 | → | 0.0% | 0.0% | 320 | → | 0.0% | 0.0% |
2024.09 | 2024/02/01 | Q1予 | 32,300 | → | 0.0% | 0.0% | 440 | → | 0.0% | 0.0% | 490 | → | 0.0% | 0.0% | 320 | → | 0.0% | 0.0% |
2024.09 | 2023/11/13 | 当初予 | 32,300 | - | - | - | 440 | - | - | - | 490 | - | - | - | 320 | - | - | - |
2023.09 | 2023/11/13 | 実 | 35,094 | ↑ | +0.3% | +0.3% | 750 | ↑ | +27.1% | +27.1% | 808 | ↑ | +26.2% | +26.2% | 556 | ↑ | +32.4% | +32.4% |
2023.09 | 2023/08/01 | Q3予 | 35,000 | → | 0.0% | 0.0% | 590 | → | 0.0% | 0.0% | 640 | → | 0.0% | 0.0% | 420 | → | 0.0% | 0.0% |
2023.09 | 2023/05/02 | Q2予 | 35,000 | → | 0.0% | 0.0% | 590 | → | 0.0% | 0.0% | 640 | → | 0.0% | 0.0% | 420 | → | 0.0% | 0.0% |
2023.09 | 2023/02/01 | Q1予 | 35,000 | → | 0.0% | 0.0% | 590 | → | 0.0% | 0.0% | 640 | → | 0.0% | 0.0% | 420 | → | 0.0% | 0.0% |
2023.09 | 2022/11/14 | 当初予 | 35,000 | - | - | - | 590 | - | - | - | 640 | - | - | - | 420 | - | - | - |
2022.09 | 2022/11/14 | 実 | 37,333 | ↑ | +5.2% | +10.5% | 944 | ↑ | +38.8% | +63.3% | 1,003 | ↑ | +37.6% | +64.2% | 657 | ↑ | +39.5% | +51.7% |
2022.09 | 2022/08/01 | Q3予 | 35,500 | ↑ | +5.0% | +5.0% | 680 | ↑ | +17.6% | +17.6% | 729 | ↑ | +19.3% | +19.3% | 471 | ↑ | +8.8% | +8.8% |
2022.09 | 2022/05/06 | Q2予 | 33,800 | → | 0.0% | 0.0% | 578 | → | 0.0% | 0.0% | 611 | → | 0.0% | 0.0% | 433 | → | 0.0% | 0.0% |
2022.09 | 2022/02/01 | Q1予 | 33,800 | → | 0.0% | 0.0% | 578 | → | 0.0% | 0.0% | 611 | → | 0.0% | 0.0% | 433 | → | 0.0% | 0.0% |
2022.09 | 2021/11/12 | 当初予 | 33,800 | - | - | - | 578 | - | - | - | 611 | - | - | - | 433 | - | - | - |
2021.09 | 2021/11/12 | 実 | 36,221 | ↑ | +3.5% | +13.9% | 713 | ↑ | +30.8% | +82.8% | 758 | ↑ | +31.8% | +78.4% | 516 | ↑ | +35.8% | +87.6% |
2021.09 | 2021/08/02 | 修正予 | 35,000 | ↑ | +10.1% | +10.1% | 545 | ↑ | +39.7% | +39.7% | 575 | ↑ | +35.3% | +35.3% | 380 | ↑ | +38.2% | +38.2% |
2021.09 | 2021/05/06 | Q2予 | 31,800 | → | 0.0% | 0.0% | 390 | → | 0.0% | 0.0% | 425 | → | 0.0% | 0.0% | 275 | → | 0.0% | 0.0% |
2021.09 | 2021/02/01 | Q1予 | 31,800 | → | 0.0% | 0.0% | 390 | → | 0.0% | 0.0% | 425 | → | 0.0% | 0.0% | 275 | → | 0.0% | 0.0% |
2021.09 | 2020/11/13 | 当初予 | 31,800 | - | - | - | 390 | - | - | - | 425 | - | - | - | 275 | - | - | - |
2020.09 | 2020/11/13 | 実 | 31,040 | ↓ | -2.1% | -2.1% | 361 | ↑ | +14.2% | +14.2% | 410 | ↑ | +15.5% | +15.5% | 378 | ↑ | +75.8% | +75.8% |
2020.09 | 2020/08/03 | Q3予 | 31,700 | → | 0.0% | 0.0% | 316 | → | 0.0% | 0.0% | 355 | → | 0.0% | 0.0% | 215 | → | 0.0% | 0.0% |
2020.09 | 2020/05/01 | Q2予 | 31,700 | → | 0.0% | 0.0% | 316 | → | 0.0% | 0.0% | 355 | → | 0.0% | 0.0% | 215 | → | 0.0% | 0.0% |
2020.09 | 2020/02/03 | Q1予 | 31,700 | → | 0.0% | 0.0% | 316 | → | 0.0% | 0.0% | 355 | → | 0.0% | 0.0% | 215 | → | 0.0% | 0.0% |
2020.09 | 2019/11/13 | 当初予 | 31,700 | - | - | - | 316 | - | - | - | 355 | - | - | - | 215 | - | - | - |
2019.09 | 2019/11/13 | 実 | 31,013 | ↓ | -2.8% | -2.8% | 283 | ↓ | -9.3% | -9.3% | 329 | ↓ | -3.2% | -3.2% | 221 | ↑ | +5.2% | +5.2% |
2019.09 | 2019/08/01 | Q3予 | 31,900 | → | 0.0% | 0.0% | 312 | → | 0.0% | 0.0% | 340 | → | 0.0% | 0.0% | 210 | → | 0.0% | 0.0% |
2019.09 | 2019/05/08 | Q2予 | 31,900 | → | 0.0% | 0.0% | 312 | → | 0.0% | 0.0% | 340 | → | 0.0% | 0.0% | 210 | → | 0.0% | 0.0% |
2019.09 | 2019/02/01 | Q1予 | 31,900 | → | 0.0% | 0.0% | 312 | → | 0.0% | 0.0% | 340 | → | 0.0% | 0.0% | 210 | → | 0.0% | 0.0% |
2019.09 | 2018/11/14 | 当初予 | 31,900 | - | - | - | 312 | - | - | - | 340 | - | - | - | 210 | - | - | - |
2018.09 | 2018/11/14 | 実 | 31,730 | ↓ | -1.3% | -1.3% | 292 | ↑ | +11.5% | +11.5% | 333 | ↑ | +14.4% | +14.4% | 305 | ↑ | +8.9% | +8.9% |
2018.09 | 2018/08/01 | Q3予 | 32,150 | → | 0.0% | 0.0% | 262 | → | 0.0% | 0.0% | 291 | → | 0.0% | 0.0% | 280 | → | 0.0% | 0.0% |
2018.09 | 2018/05/02 | Q2予 | 32,150 | → | 0.0% | 0.0% | - | - | - | - | 291 | → | 0.0% | 0.0% | 280 | → | 0.0% | 0.0% |
2018.09 | 2018/02/01 | Q1予 | 32,150 | → | 0.0% | 0.0% | 262 | → | 0.0% | 0.0% | 291 | → | 0.0% | 0.0% | 280 | → | 0.0% | 0.0% |
2018.09 | 2017/11/14 | 当初予 | 32,150 | - | - | - | 262 | - | - | - | 291 | - | - | - | 280 | - | - | - |
2017.09 | 2017/11/14 | 実 | 30,862 | ↓ | -2.0% | -2.0% | 202 | ↓ | -35.9% | -35.9% | 242 | ↓ | -29.9% | -29.9% | 133 | ↓ | -39.5% | -39.5% |
2017.09 | 2017/08/01 | Q3予 | 31,500 | → | 0.0% | 0.0% | 315 | → | 0.0% | 0.0% | 345 | → | 0.0% | 0.0% | 220 | → | 0.0% | 0.0% |
2017.09 | 2017/05/02 | Q2予 | 31,500 | → | 0.0% | 0.0% | 315 | → | 0.0% | 0.0% | 345 | → | 0.0% | 0.0% | 220 | → | 0.0% | 0.0% |
2017.09 | 2017/02/01 | Q1予 | 31,500 | → | 0.0% | 0.0% | 315 | → | 0.0% | 0.0% | 345 | → | 0.0% | 0.0% | 220 | → | 0.0% | 0.0% |
2017.09 | 2016/11/14 | 当初予 | 31,500 | - | - | - | 315 | - | - | - | 345 | - | - | - | 220 | - | - | - |
2016.09 | 2016/11/14 | 実 | 30,097 | ↓ | -2.3% | -2.3% | 197 | ↓ | -29.6% | -29.6% | 232 | ↓ | -24.2% | -24.2% | 125 | ↓ | -3.8% | -3.8% |
2016.09 | 2016/08/01 | Q3予 | 30,800 | → | 0.0% | 0.0% | 280 | → | 0.0% | 0.0% | 306 | → | 0.0% | 0.0% | 130 | → | 0.0% | 0.0% |
2016.09 | 2016/05/02 | Q2予 | 30,800 | → | 0.0% | 0.0% | 280 | → | 0.0% | 0.0% | 306 | → | 0.0% | 0.0% | 130 | → | 0.0% | 0.0% |
2016.09 | 2016/02/01 | Q1予 | 30,800 | → | 0.0% | 0.0% | 280 | → | 0.0% | 0.0% | 306 | → | 0.0% | 0.0% | 130 | → | 0.0% | 0.0% |
2016.09 | 2015/11/16 | 当初予 | 30,800 | - | - | - | 280 | - | - | - | 306 | - | - | - | 130 | - | - | - |
2015.09 | 2015/11/16 | 実 | 29,565 | ↓ | -4.3% | -4.3% | 205 | ↓ | -36.9% | -36.9% | 240 | ↓ | -30.4% | -30.4% | 159 | ↓ | -16.3% | -16.3% |
2015.09 | 2015/07/31 | Q3予 | 30,900 | → | 0.0% | 0.0% | 325 | → | 0.0% | 0.0% | 345 | → | 0.0% | 0.0% | 190 | → | 0.0% | 0.0% |
2015.09 | 2015/05/01 | Q2予 | 30,900 | → | 0.0% | 0.0% | 325 | → | 0.0% | 0.0% | 345 | → | 0.0% | 0.0% | 190 | → | 0.0% | 0.0% |
2015.09 | 2015/01/30 | Q1予 | 30,900 | → | 0.0% | 0.0% | 325 | → | 0.0% | 0.0% | 345 | → | 0.0% | 0.0% | 190 | → | 0.0% | 0.0% |
2015.09 | 2014/11/14 | 当初予 | 30,900 | - | - | - | 325 | - | - | - | 345 | - | - | - | 190 | - | - | - |
2014.09 | 2014/11/14 | 実 | 29,667 | - | - | - | 263 | - | - | - | 290 | - | - | - | 146 | - | - | - |